Exhibit 5.1
| | | | |
| | | | One Financial Center Boston, MA 02111 617 542 6000 mintz.com |
March 1, 2022
F-star Therapeutics, Inc.
Eddeva B920
Babraham Research Campus
Cambridge, CB22 3AT, United Kingdom
Re: Registration Statement on Form S-8
Ladies and Gentlemen:
We have acted as legal counsel to F-star Therapeutics, Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing with the Securities and Exchange Commission (the “Commission”) of a Registration Statement on Form S-8 (the “Registration Statement”), pursuant to which the Company is registering for issuance under the Securities Act of 1933, as amended (the “Securities Act”), an aggregate of 909,984 shares (the “Shares”) of the Company’s common stock, $0.0001 par value per share (“Common Stock”), which includes (a) 834,984 shares of Common Stock, in accordance with the terms of the 2019 Equity Incentive Plan (the “Plan”), (b) 50,000 shares of Common Stock, issuable upon the exercise of nonqualified stock options granted to an employee of the Company as an inducement material to his acceptance of employment with the Company (the “Nonqualified Stock Options”), and (c) 25,000 shares of Common Stock, issuable upon the vesting of restricted stock units to be granted to the employee of the Company as an inducement material to his acceptance of employment with the Company (the “Restricted Stock Units”). This opinion is being rendered in connection with the filing of the Registration Statement with the Commission. All capitalized terms used herein and not otherwise defined shall have the respective meanings given to them in the Registration Statement.
In connection with this opinion, we have examined the Company’s Restated Certificate of Incorporation, as amended, and Amended and Restated Bylaws, each as currently in effect; such other records of the corporate proceedings of the Company and certificates of the Company’s officers as we have deemed relevant; and the Registration Statement and the exhibits thereto.
In our examination, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as copies, the authenticity of the originals of such copies, and the truth and correctness of any representations and warranties contained therein. In addition, we have assumed that the Company will receive any required consideration in accordance with the terms of the Plan.
BOSTON LONDON LOS ANGELES NEW YORK SAN DIEGO SAN FRANCISCO WASHINGTON
MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C.